The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey

BackgroundFrequency, dimensions, management, and outcomes of the COVID-19 pandemic in children with endocrine disorders and diabetes were assessed.MethodsA cross-sectional electronic survey was distributed to the global network of endocrine societies. Respondents’ professional and practice profiles,...

Full description

Bibliographic Details
Main Authors: Nancy Samir Elbarbary, Tiago Jeronimo dos Santos, Carine de Beaufort, Esko Wiltshire, Aman Pulungan, Andrea Enzo Scaramuzza
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.735554/full
_version_ 1818836345006587904
author Nancy Samir Elbarbary
Tiago Jeronimo dos Santos
Tiago Jeronimo dos Santos
Carine de Beaufort
Carine de Beaufort
Esko Wiltshire
Esko Wiltshire
Aman Pulungan
Andrea Enzo Scaramuzza
author_facet Nancy Samir Elbarbary
Tiago Jeronimo dos Santos
Tiago Jeronimo dos Santos
Carine de Beaufort
Carine de Beaufort
Esko Wiltshire
Esko Wiltshire
Aman Pulungan
Andrea Enzo Scaramuzza
author_sort Nancy Samir Elbarbary
collection DOAJ
description BackgroundFrequency, dimensions, management, and outcomes of the COVID-19 pandemic in children with endocrine disorders and diabetes were assessed.MethodsA cross-sectional electronic survey was distributed to the global network of endocrine societies. Respondents’ professional and practice profiles, clinic sizes, their country of practice, and the impact of COVID-19 on endocrine diseases were investigated.ResultsRespondents from 131 pediatric endocrine centers in 51 countries across all continents completed the survey. Routine check-ups and education were altered in most pediatric endocrine clinics. Over 20% of clinics experienced a shortage of critical medications or essential supplies. ICU treatment was required for patients with diabetes and COVID-19 in 21.2% of centers. In diabetes, 44% of respondents reported increased diabetic ketoacidosis episodes in newly diagnosed cases and 30% in established cases. Biopsychosocial and behavioral changes were explicitly reported to be occurring among pediatric patients with endocrine disorders.ConclusionsThis large global survey conducted during the COVID-19 pandemic highlights that diabetes is more challenging to manage than any other pediatric endocrine disorder, with an increased risk of morbidity. Psychological distress due to COVID-19 needs to be recognized and addressed. The importance of close contact with healthcare professionals should be emphasized, and medical supplies should be readily available to all patients.
first_indexed 2024-12-19T03:05:07Z
format Article
id doaj.art-4bd21a4b7fea49ee9a057326af2f0232
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-19T03:05:07Z
publishDate 2021-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-4bd21a4b7fea49ee9a057326af2f02322022-12-21T20:38:08ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922021-11-011210.3389/fendo.2021.735554735554The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic SurveyNancy Samir Elbarbary0Tiago Jeronimo dos Santos1Tiago Jeronimo dos Santos2Carine de Beaufort3Carine de Beaufort4Esko Wiltshire5Esko Wiltshire6Aman Pulungan7Andrea Enzo Scaramuzza8Diabetes Unit, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, EgyptInstituto Hispalense de Pediatría, Vithas Almería, Almería, SpainDepartment of Preventive Medicine and Public Health, Universidad Autónoma de Madrid, Madrid, SpainDiabetes & Endocrine Care Clinique Pédiatrique (DECCP), Clinique Pédiatrique/Centre Hospitalier (CH) de Luxembourg, Luxembourg, LuxembourgDepartment Pediatric Endocrinology, Free University Hospital Brussels, Brussels, BelgiumDepartment of Paediatrics and Child Health, University of Otago Wellington, Wellington, New ZealandDepartment of Child Health, Capital and Coast District Health Board, Wellington, New ZealandChild Health Department, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo General Hospital, Jakarta, IndonesiaDiabetes and Endocrinology & Nutrition, Division of Pediatrics, Azienda Socio Sanitaria Territoriale (ASST) Cremona, “Ospedale Maggiore di Cremona”, Cremona, ItalyBackgroundFrequency, dimensions, management, and outcomes of the COVID-19 pandemic in children with endocrine disorders and diabetes were assessed.MethodsA cross-sectional electronic survey was distributed to the global network of endocrine societies. Respondents’ professional and practice profiles, clinic sizes, their country of practice, and the impact of COVID-19 on endocrine diseases were investigated.ResultsRespondents from 131 pediatric endocrine centers in 51 countries across all continents completed the survey. Routine check-ups and education were altered in most pediatric endocrine clinics. Over 20% of clinics experienced a shortage of critical medications or essential supplies. ICU treatment was required for patients with diabetes and COVID-19 in 21.2% of centers. In diabetes, 44% of respondents reported increased diabetic ketoacidosis episodes in newly diagnosed cases and 30% in established cases. Biopsychosocial and behavioral changes were explicitly reported to be occurring among pediatric patients with endocrine disorders.ConclusionsThis large global survey conducted during the COVID-19 pandemic highlights that diabetes is more challenging to manage than any other pediatric endocrine disorder, with an increased risk of morbidity. Psychological distress due to COVID-19 needs to be recognized and addressed. The importance of close contact with healthcare professionals should be emphasized, and medical supplies should be readily available to all patients.https://www.frontiersin.org/articles/10.3389/fendo.2021.735554/fullCOVID-19childrendiabetesobesity and metabolic syndromeadrenalthyroid
spellingShingle Nancy Samir Elbarbary
Tiago Jeronimo dos Santos
Tiago Jeronimo dos Santos
Carine de Beaufort
Carine de Beaufort
Esko Wiltshire
Esko Wiltshire
Aman Pulungan
Andrea Enzo Scaramuzza
The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
Frontiers in Endocrinology
COVID-19
children
diabetes
obesity and metabolic syndrome
adrenal
thyroid
title The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_full The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_fullStr The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_full_unstemmed The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_short The Challenges of Managing Pediatric Diabetes and Other Endocrine Disorders During the COVID-19 Pandemic: Results From an International Cross-Sectional Electronic Survey
title_sort challenges of managing pediatric diabetes and other endocrine disorders during the covid 19 pandemic results from an international cross sectional electronic survey
topic COVID-19
children
diabetes
obesity and metabolic syndrome
adrenal
thyroid
url https://www.frontiersin.org/articles/10.3389/fendo.2021.735554/full
work_keys_str_mv AT nancysamirelbarbary thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT tiagojeronimodossantos thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT tiagojeronimodossantos thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT carinedebeaufort thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT carinedebeaufort thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT eskowiltshire thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT eskowiltshire thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT amanpulungan thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT andreaenzoscaramuzza thechallengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT nancysamirelbarbary challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT tiagojeronimodossantos challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT tiagojeronimodossantos challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT carinedebeaufort challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT carinedebeaufort challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT eskowiltshire challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT eskowiltshire challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT amanpulungan challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey
AT andreaenzoscaramuzza challengesofmanagingpediatricdiabetesandotherendocrinedisordersduringthecovid19pandemicresultsfromaninternationalcrosssectionalelectronicsurvey